EPZ015666
EPZ015666
EPZ015666 抑制剂;N-[(2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基]-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺;N-((2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基)-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺 EPZ015666 抑制剂;N-[(2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基]-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺;N-((2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基)-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺 展开
1616391-65-1
C20H25N5O3
383.45
中文名称 EPZ015666
中文别名 EPZ015666 抑制剂;N-[(2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基]-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺;N-((2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基)-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺
英文名称 EPZ015666
英文别名 EPZ015666;EPZ-015666;GSK3235025;GSK-3235025;(S)-N-(3-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide;YQ36286;EPZ 015666;N-[(2s)-3-(3,4-Dihydroisoquinolin-2(1h)-Yl)-2-Hydroxypropyl]-6-(Oxetan-3-Ylamino)pyrimidine-4-Carboxamide;AK200926;3XV;GTPL8287;AOB5167;ZKXZLIFRWWKZRY-KRWDZBQOSA-N;BDBM177922;N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide;s7748;Z;GSK 3235025;BE166956;N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]-6-[(oxetan-3-yl)amino]pyrimidine-4-carboxamide;NCGC00386436-07;N-((2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide;EPZ015666 (GSK3235025);4-Pyrimidinecarboxamide, N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-6-(3-oxetanylamino)-;AC-35304;BRD-K70446295-001-01-7;CS-3995;CHEMBL4060831;AKOS027252262;EPZ015666, >=98% (HPLC);EX-A559;HY-12727;C20H25N5O3;US9675614, 166;1616391-65-1;NSC-785299;CCG-268441;P14671;NSC785299;SCHEMBL15825186;Q27077209;MFCD28411588;AS-74874;NCGC00386436-03
CAS No. 1616391-65-1
分子式 C20H25N5O3
分子量 383.45
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS